z-logo
open-access-imgOpen Access
Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China
Author(s) -
Fuqiang Cui,
Joseph Woodring,
Polin Chan,
Fujie Xu
Publication year - 2018
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyy077
Subject(s) - medicine , hbsag , hbeag , hepatitis b virus , transmission (telecommunications) , viral load , hepatitis b , virology , pediatrics , immunology , virus , electrical engineering , engineering
Treating high-risk women with antivirals in their third trimester is a promising intervention to further reduce perinatal transmission in neonates born to hepatitis B surface antigen positive [HBsAg(+)] mothers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom